Alan List - 20 Jan 2023 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
Chief Medical Officer
Signature
/s/ John Alexander Kelly, Attorney-in-fact for Alan List
Issuer symbol
DTIL
Transactions as of
20 Jan 2023
Transactions value $
$0
Form type
4
Filing time
24 Jan 2023, 15:30:17 UTC
Previous filing
28 Apr 2022
Next filing
07 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DTIL Restricted Stock Units Award $0 +180K $0.00 180K 20 Jan 2023 Common Stock 180K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Award vests in three equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.